Medincell (France) Probability of Future Stock Price Finishing Under 15.98

MEDCL Stock  EUR 16.00  0.22  1.39%   
Medincell's future price is the expected price of Medincell instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of Medincell SA performance during a given time horizon utilizing its historical volatility. Check out Medincell Backtesting, Medincell Valuation, Medincell Correlation, Medincell Hype Analysis, Medincell Volatility, Medincell History as well as Medincell Performance.
  
Please specify Medincell's target price for which you would like Medincell odds to be computed.

Medincell Target Price Odds to finish below 15.98

The tendency of Medincell Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to drop to € 15.98  or more in 90 days
 16.00 90 days 15.98 
about 44.33
Based on a normal probability distribution, the odds of Medincell to drop to € 15.98  or more in 90 days from now is about 44.33 (This Medincell SA probability density function shows the probability of Medincell Stock to fall within a particular range of prices over 90 days) . Probability of Medincell SA price to stay between € 15.98  and its current price of €16.0 at the end of the 90-day period is near 1 .
Assuming the 90 days trading horizon Medincell has a beta of 0.75. This indicates as returns on the market go up, Medincell average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Medincell SA will be expected to be much smaller as well. Additionally Medincell SA has an alpha of 0.2175, implying that it can generate a 0.22 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta).
   Medincell Price Density   
       Price  

Predictive Modules for Medincell

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Medincell SA. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Medincell's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
13.5916.0018.41
Details
Intrinsic
Valuation
LowRealHigh
13.8416.2518.66
Details
Naive
Forecast
LowNextHigh
14.5516.9619.36
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
15.5815.8716.17
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Medincell. Your research has to be compared to or analyzed against Medincell's peers to derive any actionable benefits. When done correctly, Medincell's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Medincell SA.

Medincell Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Medincell is not an exception. The market had few large corrections towards the Medincell's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Medincell SA, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Medincell within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
0.22
β
Beta against Dow Jones0.75
σ
Overall volatility
1.30
Ir
Information ratio 0.08

Medincell Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Medincell for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Medincell SA can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
The company reported the revenue of 4.09 M. Net Loss for the year was (24.81 M) with profit before overhead, payroll, taxes, and interest of 4.09 M.
Medincell SA has accumulated about 5 M in cash with (21.36 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.24.
Roughly 47.0% of the company outstanding shares are owned by corporate insiders

Medincell Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Medincell Stock often depends not only on the future outlook of the current and potential Medincell's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Medincell's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding20.1 M
Cash And Short Term Investments26.6 M

Medincell Technical Analysis

Medincell's future price can be derived by breaking down and analyzing its technical indicators over time. Medincell Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Medincell SA. In general, you should focus on analyzing Medincell Stock price patterns and their correlations with different microeconomic environments and drivers.

Medincell Predictive Forecast Models

Medincell's time-series forecasting models is one of many Medincell's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Medincell's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

Things to note about Medincell SA

Checking the ongoing alerts about Medincell for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Medincell SA help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
The company reported the revenue of 4.09 M. Net Loss for the year was (24.81 M) with profit before overhead, payroll, taxes, and interest of 4.09 M.
Medincell SA has accumulated about 5 M in cash with (21.36 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.24.
Roughly 47.0% of the company outstanding shares are owned by corporate insiders

Additional Tools for Medincell Stock Analysis

When running Medincell's price analysis, check to measure Medincell's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medincell is operating at the current time. Most of Medincell's value examination focuses on studying past and present price action to predict the probability of Medincell's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medincell's price. Additionally, you may evaluate how the addition of Medincell to your portfolios can decrease your overall portfolio volatility.